SEER*Rx - Interactive Antineoplastic Drugs Database
Released August 6, 2013

Important Update: A comprehensive review of the Federal Drug Administration (FDA) as well as other resources have provided information for the August 2013 update to SEER*RX. No drugs have changed categories as a result of this update. See Summary of Changes for all changes included in the August 2013 release.

SEER*Rx was developed as a one-step lookup for coding oncology drug and regimen treatment categories in cancer registries. The information in this database is effective for cancer diagnoses made on January 1, 2005 and after. Review and recoding of drugs from previous years is not required or recommended.

How to Access SEER*Rx

SEER*Rx is available in two formats: a web-based tool and as stand-alone software.

Web-based Version

The SEER*Rx - Interactive Antineoplastic Drugs Database is provided in a web-based format that has several benefits over the software:

  • Updates are automatic: users do not have to install anything to access the latest revisions.
  • Allows access from any computer or device with an Internet connection.
  • Eliminates problems for users who do not have permission to install software on their work computers.

Download Software Version

The web-based version of the SEER*Rx is the preferred method to access the current data. If you need the software version because of limited Internet access, it is still available for now, but may be phased out in the future. Note that the coding information in the software version of the database can get out-of-date; be sure to check back to this site to install any updates.

Download the SEER*Rx Version 2.2.0

For more information...

About state-of-the-art drugs and regimens by primary site and stage, visit the NCI's Physician Web siteExternal Web Site Policy.

About how various types of drugs work against cancer, visit the SEER Training Web siteExternal Web Site Policy.